Context Therapeutics Inc. (CNTX)
(Delayed Data from NSDQ)
$2.48 USD
-0.02 (-0.80%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.48 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.04 |
Last EPS Surprise | 50.00% |
ABR | 1.00 |
Earnings ESP
|
81.25% |
---|---|
Current Year | -0.31 |
Next Year | -0.32 |
EPS (TTM) | -1.06 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.18 | -0.31 | -0.32 |
# of Estimates | 3 | 3 | 2 | 2 |
Most Recent Consensus | -0.03 | -0.04 | -0.34 | -0.35 |
High Estimate | -0.03 | -0.04 | -0.27 | -0.28 |
Low Estimate | -0.40 | -0.44 | -0.34 | -0.35 |
Year ago EPS | -0.37 | -0.42 | -1.50 | -0.31 |
Year over Year Growth Est. | 56.76% | 57.14% | 79.33% | -3.23% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.18 | -0.31 | -0.32 |
7 Days Ago | -0.16 | -0.18 | -0.31 | -0.32 |
30 Days Ago | -0.17 | -0.19 | -0.36 | -0.33 |
60 Days Ago | -0.17 | -0.19 | -0.36 | -0.33 |
90 Days Ago | -0.17 | -0.19 | -0.36 | -0.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.03 | -0.04 | -0.31 | -0.35 |
Zacks Consensus Estimate | -0.16 | -0.18 | -0.31 | -0.32 |
Earnings ESP | 81.25% | 78.18% | 0.00% | -11.11% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.04 | -0.23 | -0.42 | -0.37 | NA |
Estimate | -0.08 | -0.38 | -0.35 | -0.30 | NA |
Difference | 0.04 | 0.15 | -0.07 | -0.07 | 0.01 |
Surprise | 50.00% | 39.47% | -20.00% | -23.33% | 11.54% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more